Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker – a retrospective multicenter study

Introduction Biologic switching is common in psoriasis patients with non-response to or adverse events under therapy with a biologic. However, evidence on efficacy of switching between newly approved biologics of similar mode of action is scarce. The objective was to assess the efficacy of treating...

Full description

Bibliographic Details
Main Authors: C. Kromer, D. Wilsmann-Theis, S. Gerdes, S. Krebs, A. Pinter, S. Philipp, R. Mössner
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2020.1716932